| RS1553568447 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553568456 |
EPHA4
|
Health Risk |
Likely pathogenic |
atypical cerebral palsy, atypical cerebral palsy |
| RS1553568528 |
TTN
|
Health Risk |
Pathogenic |
— |
| RS1553568831 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553568833 |
SCN2A
|
Health Risk |
Pathogenic |
unclassified developmental and epileptic encephalopathy, Autism spectrum disorder |
| RS1553568927 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553568970 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1553568990 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, West syndrome |
| RS1553568995 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553568999 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1553569010 |
SCN2A
|
Health Risk |
Pathogenic |
Benign familial infantile epilepsy, Benign familial infantile epilepsy |
| RS1553569017 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1553569023 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553569054 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553569081 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553569087 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553569122 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553569609 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553569659 |
SCN2A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Developmental and epileptic encephalopathy |
| RS1553569662 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553569732 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553569739 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553569754 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553569789 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553571227 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1553571813 |
SLC19A3
|
Health Risk |
Pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1553571901 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553572740 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553572946 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553572967 |
PAX3
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Waardenburg syndrome |
| RS1553572976 |
PAX3
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, See cases |
| RS1553573286 |
NDUFA10
|
Health Risk |
Likely pathogenic |
— |
| RS1553574327 |
CHRND
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS1553574522 |
SCN2A
|
Health Risk |
Pathogenic |
Self-limited epilepsy with centrotemporal spikes, Self-limited epilepsy with centrotemporal spikes |
| RS1553574531 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1553574729 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS1553574733 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1553575157 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553575159 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553575179 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553575191 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553575435 |
CHRND
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS1553575867 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS1553576452 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553576774 |
MAP3K20
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, centronuclear |
| RS1553577362 |
TTN
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1553578312 |
CHRNG
|
Health Risk |
Pathogenic |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS1553578407 |
MAP3K20
|
Health Risk |
Pathogenic |
Myopathy, centronuclear |
| RS1553578503 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553579092 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553579225 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553579251 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553579282 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553579305 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Complex neurodevelopmental disorder |
| RS1553579429 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1553579488 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553579500 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS1553579543 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553580540 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553581397 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553583434 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553583544 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1553583550 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS1553583560 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial infantile |
| RS1553583659 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553583712 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553584033 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553584053 |
SCN2A
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1553585262 |
CRYGC
|
Health Risk |
Pathogenic |
Nuclear pulverulent cataract, Cataract 2 |
| RS1553586069 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553586486 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553587071 |
TSEN2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 2B, Pontocerebellar hypoplasia type 2B |
| RS1553589058 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS1553590192 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553590211 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1553590305 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553591732 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1553591813 |
SCN2A
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1553591818 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553591922 |
TRIP12
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553592703 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553592713 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553592757 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553592766 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553592771 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553592841 |
TTN
|
Health Risk |
Pathogenic |
— |
| RS1553593030 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS1553593122 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553593177 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553593578 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS1553593589 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1553593676 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1553593874 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553593917 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553593928 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome |
| RS1553593965 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553594009 |
PAX3
|
Health Risk |
Pathogenic/Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553594069 |
PAX3
|
Health Risk |
Pathogenic/Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1553594554 |
PAX3
|
Health Risk |
Likely pathogenic |
— |
| RS1553594600 |
PAX3
|
Health Risk |
Pathogenic |
— |